Ustekinumab (Stelara): risk of exfoliative dermatitis

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
22 January 2015

Abstract

If you suspect exfoliative dermatitis caused by an adverse drug reaction to ustekinumab, stop treatment.